We serve Chemical Name:1-(2,3-Dimethylphenyl)-2-nitroethanone CAS:1311376-15-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(2,3-Dimethylphenyl)-2-nitroethanone
CAS.NO:1311376-15-4
Synonyms:Ethanone, 1-(2,3-dimethylphenyl)-2-nitro-;1-(2,3-Dimethylphenyl)-2-nitroethanone
Molecular Formula:C10H11NO3
Molecular Weight:193.199
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:339.7±30.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.537
PSA:
Exact Mass:193.073898
LogP:2.60
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Ethanone, 1-(2,3-dimethylphenyl)-2-nitro- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(2,3-Dimethylphenyl)-2-nitroethanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethanone, 1-(2,3-dimethylphenyl)-2-nitro- Use and application,1-(2,3-Dimethylphenyl)-2-nitroethanone technical grade,usp/ep/jp grade.
Related News: The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria. 5H-Pyrrolo[3,2-f]benzoxazole, 6,7-dihydro-2-(1-naphthalenyl)- manufacturers The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria. 2-butyl-1,2,4,5,6,7-hexahydro-indazol-3-one suppliers Recipharm joined the COVID-19 fight in December, signing on to produce the Moderna vaccine at its plant in Monts, France. The company hasn’t revealed if the new facilities will be engaged in COVID-19 vaccine production, though the plant in Morocco will “mirror” a new fill-finish line it added in France. 7-allyloxy-2-(4-allyloxy-3-benzyloxy-phenyl)-3,5-bis-benzyloxy-chromen-4-one vendor & factory Recipharm joined the COVID-19 fight in December, signing on to produce the Moderna vaccine at its plant in Monts, France. The company hasn’t revealed if the new facilities will be engaged in COVID-19 vaccine production, though the plant in Morocco will “mirror” a new fill-finish line it added in France.,Importance of evaluating biocatalytic processes during development
